行情

ICLR

ICLR

ICON公司
NASDAQ

实时行情|Nasdaq Last Sale

154.59
+2.17
+1.42%
盘后: 154.59 0 0.00% 16:00 11/15 EST
开盘
153.03
昨收
152.42
最高
155.52
最低
153.03
成交量
21.74万
成交额
--
52周最高
165.14
52周最低
118.10
市值
82.92亿
市盈率(TTM)
23.16
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ICLR 新闻

  • ICON plc to Present at Jefferies 2019 London Healthcare Conference
  • Business Wire.2天前
  • Investors Who Bought ICON (NASDAQ:ICLR) Shares Five Years Ago Are Now Up 191%
  • Simply Wall St..10/30 14:42
  • Edited Transcript of ICLR earnings conference call or presentation 24-Oct-19 1:00pm GMT
  • Thomson Reuters StreetEvents.10/28 21:37
  • 锁定磋商成果,中美向阶段性协议再近一步
  • 央视.10/27 22:25

更多

所属板块

生物技术和医学研究
+1.25%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

ICLR 简况

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
展开

Webull提供ICON PLC的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。